Gastrointestinal infections in the immunocompromised host

Current Opinion in Gastroenterology

Volumn 21, Issue 1, 2005, Pages 39-43

  Mehta, Sanjay ^a   Fantry, Lori ^a,b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

^c NONE   (United States)

Author keywords

AIDS; Gastrointestinal; Immunocompromised; Infection; Transplant

Indexed keywords

ABDOMINAL INFECTION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOPSY; BACTERIAL INFECTION; CRYPTOSPORIDIUM; CYTOMEGALOVIRUS INFECTION; GASTROINTESTINAL INFECTION; HISTOPLASMA CAPSULATUM; HUMAN; IMMUNE DEFICIENCY; ISOSPORA BELLI; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NEMATODIASIS; NOCARDIA BRASILIENSIS; REVIEW; STRONGYLOIDES; TUBERCULOSIS;

BACTERIAL INFECTIONS; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; INFECTION; INTESTINAL DISEASES, PARASITIC; MYCOSES; VIRUS DISEASES;

EID: 13244265846     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Organ Procurement and Transplantation Network: Scientific registry of transplant recipients: fast facts about transplants, January 1,2003-December 31,2003. 2004. www.ustransplant.org
2. Centers for Disease Control and Prevention: HIV/AIDS surveillance report 2003 MMWR 2003, Survey report vol. 14.
3. Joint Conference UN Program on HIV/AIDS: 2004 Report on the Global AIDS Epidemic 2004.
4. Poles MA, Barsoum S, Yu W, et al.: Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy. J Virol 2003, 77:10456-10467.
5. Guadalupe M, Reay E, Sankaran S, et al.: Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003, 77:11708-11717.
6. Veazey R, Lackner A: The mucosal immune system and HIV-1 infection. AIDS Rev 2003, 5:245-252. This is a detailed review of HIV and the mucosal immune system clarifying the relationship between features of HSV esophagitis.
7. Itoh T, Takahashi T, Kusaka K, et al.: Herpes simplex esophagitis from 1307 autopsy cases. J Gastroenterol Hepatol 2003, 18:1407-1411. This is a large review of autopsy cases of histopathologically proven HSV esophagitis that characterizes the macroscopic and microscopic features of this disease.
8. Moore RD, Chaisson RE: Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996, 124:633-642.
9. Okeke EN, Agaba EI, Achinge GI, Malu AO: Upper gastrointestinal endoscopic findings in patients with HIV/AIDS at the Jos University Teaching Hospital, Nigeria. Niger J Med 2003, 12:202-205.
10. Anekthananon T, Ratanasuwan W, Techasathit W, et al.: HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention. J Med Assoc Thai 2004, 87:173-179.
11. Ruhnke M: Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatment. Drugs 2004, 64:1163-1180. This is an excellent review of treatment of fungal infections, including esophagitis, in AIDS patients.
12. Keating G, Figget D: Caspofungin: a review of its use in esophageal candidiasis, invasive candidiasis, and invasive aspergillosis. Drugs 2003, 63: 2235-2263. This is another high-quality review of the use of caspofungin for candidiasis and invasive aspergillosis.
13. Kartsonis NA, Saah A, Lipka CJ, et al.: Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study. J Antimicrob Chemother 2004, 53:878-881.
14. Hernadez S, Lopez-Ribot JL, Najvar LK, et al.: Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis. Antimicrob Agents Chemother 2004, 48:1382-1383. This article is important because it correlates in vitro caspofungin resistance with clinical outcomes.
15. Tessari G, Forni A, Ferretto R, et al.: Lethal systemic dissemination from a cutaneous infection due to Curvularia lunata in a heart transplant recipient. J Eur Acad Dermatol Venereol 2003, 17:440-442.
16. Chiu HM, Wu MS, Hung CC, et al.: Low prevalence of Helicobacter pylori but high prevalence of cytomegalovirus-associated peptic ulcer disease in AIDS patients: comparative study of symptomatic subjects evaluated by endoscopy and CD4 counts. J Gastroenterol Hepatol 2004, 19:423-428. This is an important study because it contradicts prior beliefs about the causes of gastric ulcers in AIDS patients.
17. Monforte-Munoz H, Kapoor N, Saavedra JA: Epstein-Barr virus-associated leiomyomatosis and posttransplant lymphoproliferative disorder in a child with severe combined immunodeficiency: case report and review of the literature. Pediatr Dev Pathol 2003, 6:449-457.
18. Koehler JE, Sanchez MA, Tye S, et al.: Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis 2003, 37:559-566.
19. Chetty R, Sabaratnam RM: Upper gastrointestinal bacillary angiomatosis causing hematemesis: a case report. Int J Surg Pathol 2003, 11:241-244.
20. Pinchoff RJ, Kaufman SS, Magid MS, et al.: Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 2003, 76:183-189. This is an important study because it documents the significance of adenovirus infection in pediatric small bowel transplant recipients.
21. Patino C, Fontes B, Poggetti RS, et al.: Bile duct-duodenal fistula caused by AIDS/HIV-associated tuberculosis. Rev Hosp Clin Fac Med Sao Paulo 2003, 58:223-226.
22. John MA, Madiba TE, Mahabeer P, et al.: Disseminated nocardiosis masquerading as abdominal tuberculosis. S Afr J Surg 2004, 42:17-19.
23. Tarantino L, Giorgio A, de Stefano G, et al.: Disseminated mycobacterial infection in AIDS patients: abdominal US features and value of fine-needle aspiration biopsy of lymph nodes and spleen. Abdom Imaging 2003, 28:602-608.
24. Nicholson AM, Rainford L, Elliott V, Christie CD: Disseminated histoplasmosis and AIDS at the University Hospital of the West Indies: a case report. West Indian Med J 2004, 53:126-130.
25. Botero JH, Castano A, Montoya MN, et al.: A preliminary study of the prevalence of intestinal parasites in immunocompromised patients with and without gastrointestinal manifestations. Rev Inst Med Trop Sao Paulo 2003, 45:197-200.
26. Cranendonk RJ, Kodde CJ, Chepeta D, et al.: Cryptosporidium parvum and Isospora belli infections among patients with and without diarrhea. East Afr Med J 2003, 80:393-394.
27. Certad G, Arenas-Pinto A, Pocaterra L, et al.: Isosporiasis in Venezuelan adults infected with human immunodeficiency virus: clinical characterization. Am J Trop Med Hyg 2003, 69:217-222. This is an excellent epidemiologic study and review of isosporiasis in Venezuela.
28. Resiere D, Vantelon JM, Bouree P, et al.: Isospora belli infection in a patient with non-Hodgkin's lymphoma. Clin Microbiol Infect 2003, 9:1065-1067.
29. Arenas-Pinto A, Certad G, Ferrara G, et al.: Association between parasitic intestinal infections and acute or chronic diarrhoea in HIV-infected patients in Caracas, Venezuela. Int J STD AIDS 2003, 14:487-492.
30. Sulaiman IM, Matos O, Lobo ML, Xiao L: Identification of a new microsporidian parasite related to Vittaforma corneae in HIV-positive and HIV-negative patients from Portugal. J Eukaryot Microbiol 2003, 50(suppl):586-590.
31. Keiser PB, Nutman TB: Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004, 17:208-217.
32. Safdar A, Malathum K, Rodriguez SJ, et al.: Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 2004, 100:1531-1536. This study is remarkable for the large number of cancer cases included.
33. Schaeffer MW, Buell JF, Gupta M, et al.: Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant 2004, 23:905-911.
34. Potter A, Stephens D, De Keulenaer B: Strongyloides hyper-infection: a case for awareness. Ann Trop Med Parasitol 2003, 97:855-860.
35. Hong IS, Zaidi SY, McEvoy P, Neafie RC: Diagnosis of Strongyloides stercoralis in a peritoneal effusion from an HIV-seropositive man: a case report. Acta Cytol 2004, 48:211-214.
36. Courouble G, Rouet F, Herrmann-Storck C, et al.: Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies). West Indian Med J 2004, 53:3-6.
37. Satoh M, Kiyuna S, Shiroma Y, et al.: Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1. Clin Exp Immunol 2003, 133:391-396.
38. Marchi Blatt J, Cantos GA: Evaluation of techniques for the diagnosis of Strongyloides stercoralis in human immunodeficiency virus (HIV) positive and HIV negative individuals in the city of Itajai, Brazil. Braz J Infect Dis 2003, 7:402-408.
39. Machado ER, Ueta MT, de Fatima Goncalves-Pires Mdo R, et al.: Strongyloides venezuelensis alkaline extract for the diagnosis of human strongyloidiasis by enzyme-linked immunosorbent assay. Mem Inst Oswaldo Cruz 2003, 98:849-851.
40. Ng KL, Ho J, Ng HS, Luman W: Gastrointestinal cytomegalovirus infection in non-human immunodeficiency virus infected patients. Med J Malaysia 2003, 58:337-344.
41. Schulenburg A, Turetschek K, Wrba F, et al.: Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol 2004, 83:101-106.
42. Pulvirenti JJ, MehraT, Hafiz I, et al.: Epidemiology and outcome of Clostridium difficile infection and diarrhea in HIV infected inpatients. Diagn Microbiol Infect Dis 2002, 44:325-330.
43. De Toledo FG, Symes SN: Leukemoid reaction due to Clostridium difficile infection in Acquired Immunodeficiency Syndrome: two case reports and a review of the literature. Sout Med J 2004, 97:388-392.
44. Pop M, Pop C, Homorodean D, et al.: Abdominal miliary tuberculosis in a patient with AIDS: a case report. Rom J Gastroenterol 2003, 12:231-234.
45. Korner M, Gebbers JO: Clinical significance of human intestinal spirochetosis: a morphologic approach. Infection 2003, 31:341-349.
46. Jensen TK, Teglbjaerg PS, Lindboe CF, Boye M: Demonstration of Brachyspira aalborgi lineages 2 and 3 in human colonic biopsies with intestinal spirochaetosis by specific fluorescent in situ hybridization. J Med Microbiol 2004, 53:341-343.
47. van Mook WN, Koek GH, van der Ven AJ, et al.: Human intestinal spirochaetosis: any clinical significance? Eur J Gastroenterol Hepatol 2004, 16:83-87.
48. Koteish A, Kannangai R, Abraham SC, Torbenson M: Colonic spirochetosis in children and adults. Am J Clin Pathol 2003, 120:828-832.
49. Weinstein RA: Planning for epidemics: the lessons of SARS. N Engl J Med 2004, 350:2332-2334.
50. Peiris J, Yuen KY, Osterhaus A, Stöhr K: Current concepts: the severe acute respiratory syndrome. N Engl J Med 2003, 349:2431-2441.